title: [JSN treatment guideline for Parkinson's disease: its editorial policy and problems to be addressed].
abstract: The main part of "JSN Treatment Guideline for Parkinson's Disease 2011" was made according to the strict principles of evidence-based medicine(EBM), which was described in "Minds: A guidebook for preparation of practice guidelines 2007". In brief, the methodology represents determination of recommendations, based on the results of the literature searches for evidence for clinical questions by systematic methods. This guideline also contains systematic reviews for drug and surgical treatments of Parkinson's disease, which is entitled "Effectiveness and safety for anti-Parkinsonian drugs and surgical treatments" Handling of treatment algorithms, handling of cost-effectiveness analysis of treatments, and consideration for the influence of guidelines to the general society are the important issues to be addressed in the near future.
authors.affiliation: Department of Neurology, Kyoto University Graduate School of Medicine.
authors.forename: Ryosuke
authors.initials: R
authors.lastname: Takahashi
mesh_terms: D000978:Antiparkinson Agents; D003362:Cost-Benefit Analysis; D019317:Evidence-Based Medicine; D006801:Humans; D007564:Japan; D009462:Neurology / Q000458:organization & administration*; D019635:Neurosurgical Procedures; D010300:Parkinson Disease / Q000191:economics / Q000628:therapy*; D017410:Practice Guidelines as Topic; D012955:Societies, Medical / Q000458:organization & administration*
chemical_list: D000978:Antiparkinson Agents